Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG33 repeat length in the Huntington's disease gene

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 925-927

  Squitieri, Ferdinando ^a   Esmaeilzadeh, Mouna ^b   Ciarmiello, Andrea ^c   Jankovic, Joseph ^d  

^a IRCCS NEUROMED   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; HUNTINGTIN;

AGED; ALLELE; BRAIN METABOLISM; CAG REPEAT; CASE REPORT; CAUDATE GLUCOSE HYPOMETABOLISM; CAUDATE NUCLEUS; DISEASE SEVERITY; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; LEFT HEMISPHERE; LETTER; MALE; METABOLIC DISORDER; METABOLIC RATE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RIGHT HEMISPHERE;

AGED; CAUDATE NUCLEUS; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; HUNTINGTON DISEASE; MALE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POSITRON-EMISSION TOMOGRAPHY; TRINUCLEOTIDE REPEATS;

EID: 79955114300     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23623     Document Type: Letter

References (8)

1. ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet 1998; 62: 1243-1247.
2. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord 2007; 22: 127-130.
3. Andrich J, Arning L, Wieczorek S, Kraus PH, Gold R, Saft C. Huntington's disease as caused by 34 CAG repeats. Mov Disord 2008; 23: 879-881.
4. Herishanu YO, Parvari R, Pollack Y, et al. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? J Neurol Sci 2009; 277: 143-146.
5. Groen JL, de Bie RM, Foncke EM, et al. Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry 2010; 81: 228-230.
6. Seong IS, Ivanova E, Lee JM, et al. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 2005; 14: 2871-2880.
7. Swami M, Hendricks AE, Gillis T, et al. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet 2009; 18: 3039-3047.
8. Squitieri F, Ciarmiello A. Key role of nuclear medicine in seeking biomarkers of Huntington's disease. Eur J Nucl Med Mol Imaging 2010; 37: 1124-1127.